Heike Schumacher

Heike Schumacher

Auto-generated profile, based on publicly available information

Heike Schumacher

German Center for Neurodegenerative Diseases (DZNE) Berlin, Charitéplatz 1, 10117, Berlin, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Neurobiology of Disease
Verified
Journal Article
Closed access
AOAnna G. Orr
Anna G. Orr
ILIris Lo
Iris Lo
HSHeike Schumacher
Heike Schumacher
KHKaitlyn Ho
Kaitlyn Ho
MGMichael Gill
Michael Gill
LMLennart Mucke
Lennart Mucke

14 March 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
HSHeike Schumacher
Heike Schumacher
TMThomas Meyer
Thomas Meyer
HPHarald Prüss
Harald Prüss
In 2010 the spectrum of known antigens in autoimmune encephalitis has been expanded by GABAB receptors. Until now over 80 patients with GABAB receptor encephalitis have been described. We report the occurrence of GABAB receptor antibodies in a patient with clinically diagnosed amyotrophic lateral sclerosis (ALS). GABAB receptor antibodies have not been described previously in an ALS patient. A 75-year-old female patient presented with cerebellar ataxia, bulbar palsy and cognitive impairment. In the later course of disease signs for affection of the second motor neuron evolved and she was diagnosed with ALS. A post-mortem analysis of cerebrospinal fluid revealed high titers of GABAB receptor antibodies. This case provides an idea of the natural course of GABAB receptor encephalitis and demonstrates that antibody-mediated autoimmunity could be one of several pathways leading to the ALS phenotype. Furthermore this unique case stimulates the question whether neuronal antibodies might be more common in ALS than previously suspected.